Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 4/2005

01-08-2005 | Letter

A case of dermatomyositis associated with papillary cancer of the thyroid gland

Authors: J.-H. Lee, S.-I. Kim

Published in: Clinical Rheumatology | Issue 4/2005

Login to get access

Excerpt

The frequency of malignancy associated with dermatomyositis (DM) is 6–60%, significantly higher than in normal populations. It occurs particularly in ovarian, lung, pancreatic, stomach, and colorectal cancers and non-Hodgkin’s lymphoma [1, 2, 3]. The association between DM and malignancy of the thyroid gland is rare. We report a case of DM associated with papillary cancer of the thyroid gland. …
Literature
1.
Catherine LH, Yuqing Z, Bardur S, Eero P, Lene M, Antti A, Stephen RE (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed
2.
Antti A, Eero P, Heikki I (1995) Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 22:1300–1303PubMed
3.
Bardur S, Bernt L, Olof E, Erik A (1992) Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 326:363–367PubMed
4.
Hatada T, Aoli I, Ikeda h, Tamura T, Okada K, Nakai T, Utsunomiya J (1996) Dermatomyositis and malignancy: case report and review of the Japanese literature. Tumori 82:273–275PubMed
5.
Archambeaud MF, Bernard P, Laroumagne G, Dejax C, Vallat JM (1986) Dermatomyositis associated with cancer of the thyroid. Favourable course after iodine-131 irradiation. Presse Med 15:1928
6.
Philippe C, Slim S, Isabelle T, Bernard F, Antoine F (1989) Thyroid plasmacytoma with dermatomyositis and palmar fasciitis. J Rheumatol 16:997–999PubMed
7.
Adel GF (2000) Paraneoplastic rheumatic syndrome. Baillieres Clin Rheumatol 14:515–533
8.
Fudman EJ, Schnitzer TJ (1986) Dermatomyositis without creatinine kinase elevation: poor prognostic sign. Am J Med 80:329–332CrossRefPubMed
9.
Caldwell DS, McCallum RM (1986) Rheumatologic manifestations of cancer. Med Clin North Am 70:385–417PubMed
10.
11.
Carson S (1997) The association of malignancy with rheumatic and connective tissue disease. Semin Oncol 24:360–372PubMed
Metadata
Title
A case of dermatomyositis associated with papillary cancer of the thyroid gland
Authors
J.-H. Lee
S.-I. Kim
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0979-3

Other articles of this Issue 4/2005

Clinical Rheumatology 4/2005 Go to the issue

Original Article

Raynaud’s phenomenon in a healthy Turkish population

Case Report

A case of post-pregnancy osteoporosis-related spinal fractures in association with ankylosing spondylitis

Case Report

Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case

Case Report

Reactive arthritis following BCG immunotherapy for bladder carcinoma

Original Article

Trace elements and some extracellular antioxidant proteins levels in serum of patients with systemic lupus erythematosus

Original Article

Oesophageal manometry in early and definite systemic sclerosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits